Community evidence can become policy, financing and institutional practice.

This page does not repeat the chronology. It groups results by theme — so a reader sees what changed in rules, money and practice.

2014first public procurement of ARV
2021100% public ARV financing
8policy areas
A — How a regulatory change happens

From a patient complaint to a working rule.

01Patient complaints

Community data shows the gap between formally adopted rules and their implementation.

02Practice monitoring

Barrier analysis based on practice monitoring.

03International standards

International standards are used as the benchmark.

04Proposals

Proposals to revise protocols, orders, standards and legislation.

05Implementation oversight

Policy change → implementation oversight.

B — Selected system-level achievements

Eight areas. Open a card for the full case.

01 · Challenge

ARV procurement depended on external financing, making treatment access systemically vulnerable.

02 · Role

Advocacy coordinator / coalition participant

03 · Result
  • 012013–2014 — “For Life” rallies for state procurement
  • 022014 — first public procurement of ARV medicines
  • 032021 — ARV expenditures fully covered by the state budget
01 · Challenge

Hepatitis C treatment was available to an extremely limited number of patients.

02 · Role

Community / patient advocate

03 · Result
  • 01Access advocacy and a public action at the Ministry of Health
  • 022016 — access to medicines secured (from ~300 patients)
  • 032026 — annual treatment coverage of 15,000 people
01 · Challenge

Buprenorphine was not included in the protocols; treatment initiation criteria, permitted dosages and take-home conditions needed revision.

02 · Role

Community representative / protocol contributor

03 · Result
  • 01Buprenorphine incorporated into protocols
  • 02Treatment initiation criteria and permitted dosages revised
  • 03Take-home supply for stable patients for one week or longer
01 · Challenge

Prevention was tied to a stigmatising group label rather than to need and risk.

02 · Role

Community systems advocate

03 · Result
  • 01Services provided through ARV treatment sites
  • 02Community PrEP developed and introduced
  • 03Prevention de-linked from a single stigmatised group
01 · Challenge

Harm reduction was limited to distributing commodities; there was no national costing methodology for services or electronic service registration.

02 · Role

Policy / standards contributor

03 · Result
  • 01Work with additional vulnerable populations
  • 02National costing methodology for services approved by the Ministry of Health
  • 03Electronic service registration system introduced
01 · Challenge

A punitive draft law included a provision requiring mandatory reporting to the police.

02 · Role

Community representative / policy contributor

03 · Result
  • 01Development of a patient-centred drug strategy
  • 02Punitive draft law returned for revision
  • 03Mandatory reporting to the police removed
01 · Challenge

People living with HIV and couples with different HIV status had no access to assisted reproductive services.

02 · Role

Advocacy / policy coalition

03 · Result
  • 01January 2020 — Ministry of Health Order No. 83
  • 02Access for people living with HIV
  • 03Access for couples with different HIV status
01 · Challenge

A gap between formally adopted rules and their implementation.

02 · Role

Member of a multisectoral team

03 · Result
  • 01Patient complaints and practice monitoring
  • 02International standards as a benchmark
  • 03Proposals to revise protocols, orders, standards and legislation